Display options
Cite
Almhanna K, Weber J, Shridhar R, et al. Determining the optimal number of lymph nodes harvested during esophagectomy. J Gastrointest Oncol. 2016;7(3):387-94doi: 10.21037/jgo.2015.12.02.
Almhanna, K., Weber, J., Shridhar, R., Hoffe, S., Strosberg, J., & Meredith, K. (2016). Determining the optimal number of lymph nodes harvested during esophagectomy. Journal of gastrointestinal oncology, 7(3), 387-94. https://doi.org/10.21037/jgo.2015.12.02
Almhanna, Khaldoun, et al. "Determining the optimal number of lymph nodes harvested during esophagectomy." Journal of gastrointestinal oncology vol. 7,3 (2016): 387-94. doi: https://doi.org/10.21037/jgo.2015.12.02
Almhanna K, Weber J, Shridhar R, Hoffe S, Strosberg J, Meredith K. Determining the optimal number of lymph nodes harvested during esophagectomy. J Gastrointest Oncol. 2016 Jun;7(3):387-94. doi: 10.21037/jgo.2015.12.02. PMID: 27284471; PMCID: PMC4880760.
Copy Download .nbib Format: NLM
Share it on

J Gastrointest Oncol. 2016 Jun;7(3):387-94. doi: 10.21037/jgo.2015.12.02.

Determining the optimal number of lymph nodes harvested during esophagectomy.

Journal of gastrointestinal oncology

Khaldoun Almhanna, Jill Weber, Ravi Shridhar, Sarah Hoffe, Jonathan Strosberg, Kenneth Meredith

Affiliations

  1. Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida 334612, USA.

PMID: 27284471 PMCID: PMC4880760 DOI: 10.21037/jgo.2015.12.02

Abstract

BACKGROUND: We examined the impact of the number of lymph nodes (LNs) removed during esophagectomy on outcomes in esophageal cancer (EC).

METHODS: From a comprehensive EC database we identified patients who underwent curative resection from 1994 to 2011. The impact of total LNs retrieved on disease-free survival (DFS) and overall survival (OS) was investigated.

RESULTS: In total, 635 patients were identified. Patients were divided on the basis of total number of LNs removed (<8, 9-12, 13-20, and >20). The 5-year OS and DFS rates for the group by LN category were (43%, 42%, 55%, and 36%, P=0.1836) and (44%, 37%, 46%, and 36%, P=0.5166), respectively. Total number of LNs assessed did not correlate with reduced risk of recurrence or improved survival. On multivariate analysis controlling for age, sex, histology, neoadjuvant therapy, only removal of 13-20 LN's correlated to improved oncologic outcomes.

CONCLUSIONS: In a tertiary cancer center, we demonstrated that only removal of 13-20 LNs during esophagectomy correlated to improved survival. While the importance of standardized pathologic examination and adequate nodal staging is of utmost importance for patients with EC undergoing esophagectomy the optimum number of LNs removed clearly warrants further investigation.

Keywords: Esophagectomy; lymph nodes (LN); neoadjuvant therapy

References

  1. Cancer. 2008 Mar 15;112(6):1239-46 - PubMed
  2. Ann Surg. 2010 Jan;251(1):46-50 - PubMed
  3. Recent Results Cancer Res. 2000;155:123-33 - PubMed
  4. Br J Surg. 2001 May;88(5):715-9 - PubMed
  5. CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300 - PubMed
  6. J Gastrointest Surg. 2007 Feb;11(2):158-65 - PubMed
  7. Br J Surg. 2002 Jul;89(7):909-13 - PubMed
  8. J Surg Oncol. 2011 Apr;103(5):416-20 - PubMed
  9. J Chronic Dis. 1987;40(5):373-83 - PubMed
  10. N Engl J Med. 2002 Nov 21;347(21):1662-9 - PubMed
  11. Am J Surg. 2005 Jan;189(1):98-109 - PubMed
  12. Am J Surg. 1998 Jan;175(1):47-51 - PubMed
  13. J Gastrointest Surg. 2007 Nov;11(11):1384-93; discussion 1393-4 - PubMed
  14. Br J Surg. 2000 Oct;87(10):1426-33 - PubMed
  15. J Thorac Oncol. 2010 May;5(5):707-12 - PubMed
  16. N Engl J Med. 2003 Nov 27;349(22):2117-27 - PubMed
  17. Ann Surg Oncol. 2006 Sep;13(9):1189-200 - PubMed
  18. Ann Surg. 2002 Aug;236(2):177-83 - PubMed
  19. Ann Surg. 2008 Oct;248(4):549-56 - PubMed
  20. J Clin Oncol. 2005 Oct 1;23(28):7114-24 - PubMed

Publication Types